4//SEC Filing
Marango Jotin 4
Accession 0000950170-25-099848
CIK 0001835579other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:32 PM ET
Size
12.3 KB
Accession
0000950170-25-099848
Insider Transaction Report
Form 4
Marango Jotin
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−181,000→ 0 total→ Common Stock (181,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−397,199→ 0 total→ Common Stock (397,199 underlying) - Tax Payment
Common Stock
2025-07-28$17.16/sh−4,630$79,451→ 11,146 total - Award
Common Stock
2025-07-28+15,776→ 15,776 total - Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−105,000→ 0 total→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena.
Documents
Issuer
ImageneBio, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0001777513
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 9:32 PM ET
- Size
- 12.3 KB